Back to company

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: Financial statements 2021

CVR: 19040089

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN (CVR 19040089) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 1,797,096 and a net result of DKK 1,626,588 compared with DKK 950,846 the year before. That is a decrease of 11.1% compared with the year before. The profit margin was 90.5%. Equity amounted to DKK 15,897,786. The solvency ratio was 97.4%.

Revenue
1,797,096 kr.
Gross Profit
494,701 kr.
Profit/Loss
1,626,588 kr.
Equity
15,897,786 kr.
Total Assets
16,325,688 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20211.8 mio.495 t.1.6 mio.15.9 mio.-
20202 mio.586 t.951 t.15.5 mio.-
20191.7 mio.-87 t.1.9 mio.14.9 mio.0
20181.6 mio.282 t.-240 t.13.9 mio.0
20172.3 mio.617 t.962 t.14.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: The 2020 annual report is outJun 30, 2021

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN has published its annual report for 2020. Revenue came to DKK 2,021,234, and the net result was DKK 950,846.

About ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN is a Danish company of the type Erhvervsdrivende fond based in København V, founded in 1999. The company is registered under the industry Andre udgiveraktiviteter, undtagen udgivelse af software. The management consists of Sören Erik Pischke. In 2024, the company reported revenue of DKK 2,351,812 and a net result of DKK 1,569,542 compared with DKK 1,366,095 the year before. Equity amounted to DKK 14,950,740.